Meloxicam Capsule 7.5 mg (Meloxicam)

Adult dose

1. Acute exacerbation of osteoarthritis (degenerative arthritis) ○ Adults: Administer meloxicam 7.5 mg orally once daily. If symptoms do not improve, the dose may be increased to 15 mg per day as needed. 2. Rheumatoid arthritis, ankylosing spondylitis: ○ Adults: Administer meloxicam 15 mg orally once daily. The dose may be reduced to 7.5 mg per day according to response to treatment. Do not administer more than 15 mg per day. Take the daily dose all at once with water or another beverage during a meal. ○ In elderly patients or those at increased risk of adverse reactions (e.g., history of gastrointestinal disease or cardiovascular risk factors), treatment is usually started at a dose of 7.5 mg per day. ○ Patients with severe renal impairment receiving hemodialysis should not be administered more than 7.5 mg per day.

Caution should be taken when this medication is used by individuals who regularly consume more than three glasses of alcohol per day, as it may increase the risk of gastrointestinal bleeding; consultation with a doctor or pharmacist is essential. This medication may affect the cardiovascular system and increase the risk of serious thrombotic events such as myocardial infarction or stroke, thus those with cardiovascular disease or risk factors should be closely monitored. This medication can cause severe adverse reactions such as ulcers, bleeding, and perforations in the gastrointestinal tract, so care should be taken particularly by individuals with a history of gastrointestinal diseases or the elderly. Serious allergic reactions or hypersensitivity reactions may occur, and if symptoms such as skin rash or mucosal damage appear, immediately discontinue use. This medication may affect kidney function; therefore, individuals with kidney disease, the elderly, or those taking diuretics or blood pressure medications should regularly check their kidney function. It may reduce reproductive ability, so women planning pregnancy should avoid taking this medication. This medication should not be used in specific allergic patients or individuals with severe liver, kidney, or heart disease, those under 15 years of age, pregnant women, and breastfeeding mothers. Regular blood tests and checks of liver and kidney function should be conducted during prolonged use to detect adverse reactions early and respond appropriately. The risk of bleeding may increase when taken in combination with other anti-inflammatory analgesics or medications that affect blood coagulation; therefore, a doctor's guidance should be followed. This medication must not be taken during pregnancy, particularly in the later stages, as it may severely affect the fetus; it is also advised not to use it while breastfeeding. The elderly, having weakened bodily functions, may have a higher likelihood of side effects and should use it cautiously at the minimum dosage. In case of overdose, gastrointestinal bleeding, kidney and liver damage, and severe poisoning symptoms may occur, necessitating immediate medical attention for appropriate treatment. This medication should be stored out of reach of children and kept sealed in its original container to maintain its quality.

• Gastrointestinal bleeding
• cardiovascular thrombotic events
• myocardial infarction
• stroke
• gastrointestinal or intestinal bleeding
• ulcers
• perforation
• exfoliative dermatitis
• mucocutaneous syndrome
• toxic epidermal necrolysis

This medication is sensitive to light and should be stored in a container that protects it from light. It is also recommended to store it at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness and safety.

Appearance

A hard capsule in light green color containing a light yellow powder

Package unit

30 capsules/bottle, 300 capsules/bottle